 | Up a level |
Journal Article
Beer, Andrea, Holzmann, Heidemarie, Pischke, Sven, Behrendt, Patrick, Wrba, Fritz, Schlue, Jerome, Drebber, Uta, Neudert, Barbara, Halilbasic, Emina, Kreipe, Hans, Lohse, Ansgar, Sterneck, Martina, Wedemeyer, Heiner, Manns, Michael and Dienes, Hans P. (2019). Chronic Hepatitis E is associated with cholangitis. Liver Int., 39 (10). S. 1876 - 1884. HOBOKEN: WILEY. ISSN 1478-3231
Traussnigg, Stefan, Schattenberg, Jorn M. 
ORCID: 0000-0002-4224-4703, Demir, Muenevver, Wiegand, Johannes, Geier, Andreas, Teuber, Gerlinde, Hofmann, Wolf Peter, Kremer, Andreas E., Spreda, Frank, Kluwe, Johannes, Petersen, Joerg, Boettler, Tobias ORCID: 0000-0002-1195-055X, Halilbasic, Emina, Greinwald, Roland, Proels, Markus, Manns, Michael P., Fickert, Peter and Trauner, Michael H.
(2017).
norUrsodeoxycholic acid (norUDCA) improves non-alcoholic fatty liver disease (NAFLD): Results from a randomized placebo-controlled, double-blind phase IIa study.
Hepatology, 66.
S. 106A - 108.
HOBOKEN:
WILEY.
ISSN 1527-3350
Traussnigg, Stefan, Schattenberg, Jorn M. ORCID: 0000-0002-4224-4703, Demir, Munevver, Wiegand, Johannes, Geier, Andreas, Teuber, Gerfinde, Hofmann, Wolf Peter, Kremer, Andreas E., Spreda, Frank, Kluwe, Johannes, Petersen, Jorg, Boettler, Tobias ORCID: 0000-0002-1195-055X, Rainer, Florian, Halilbasic, Emina, Greinwald, Roland, Prols, Markus, Manns, Michael P., Fickert, Peter and Trauner, Michael ORCID: 0000-0002-1275-6425
(2019).
Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial.
Lancet Gastroenterol. Hepatol., 4 (10).
S. 781 - 794.
SAN DIEGO:
ELSEVIER INC.
ISSN 2468-1253